3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
23
Head & Neck
3
Thoracic
2
Gynecologic
2
Breast
2
Plasma cell
1
Gastrointestinal
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
1883
Lung Neoplasms
1308
Small Cell Lung Carcinoma
329
Colorectal Neoplasms
271
Breast Neoplasms
243
Melanoma
221
Neoplasms
218
Ovarian Neoplasms
193
Neoplasm Metastasis
181
Pancreatic Neoplasms
155
Squamous Cell Carcinoma of Head and Neck
152
Stomach Neoplasms
143
Head and Neck Neoplasms
120
Carcinoma, Renal Cell
119
Triple Negative Breast Neoplasms
111
Esophageal Neoplasms
109
Prostatic Neoplasms
107
Endometrial Neoplasms
98
Uterine Cervical Neoplasms
97
Urinary Bladder Neoplasms
89
Mesothelioma
88
Colonic Neoplasms
86
Mesothelioma, Malignant
81
Carcinoma, Hepatocellular
74
Brain Neoplasms
70
Sarcoma
64
Disease
63
Adenocarcinoma of Lung
60
Carcinoma, Transitional Cell
54
Liver Neoplasms
49
Interventions
pembrolizumab
1
futibatinib
1
Histamine H2 Antagonists
1
Famotidine
1
Erlotinib Hydrochloride
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Thoracic
×
1 year
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled
NCT05827614
2026-01-23
POTENTIATE
Boundless Bio, Inc.
Phase 1
Active not recruiting
85 enrolled